Fill in the form below and our experts will get back to you within 1 business day.
Accelerate your research with custom DNA and RNA oligos consistently manufactured to your exact specifications. From routine PCR primers to complex therapeutic oligonucleotides, we deliver NGS-verified synthetic nucleic acids with industry-leading turnaround times.
Trusted by leading research and pharmaceutical institutions
Oligos, genes, and modified nucleic acids
Mass spec and CE verification
Multiple scales and purifications
Our platform combines established phosphoramidite chemistry with cutting-edge enzymatic synthesis technologies.
Proven phosphoramidite chemistry with optimized coupling efficiency. Our proprietary synthesis platforms deliver more full-length product than other suppliers, with 99.9% coupling efficiency and rigorous QC at every step.
Next-generation TdT-based synthesis using engineered terminal deoxynucleotidyl transferase with reversible terminators. Template-independent de novo synthesis without toxic reagents.
All 20 amino acids at target positions with optimized degenerate codons.
Every library undergoes next-generation sequencing verification with detailed reports.
From single-site saturation to complex combinatorial libraries.
Get a customized quote for your DNA/RNA synthesis project.
Industry-leading synthesis platforms ensuring high-quality output for every project.
Optimized phosphoramidite chemistry with better coupling efficiency than other suppliers, delivering more full-length product.
Every oligo undergoes ESI mass spectrometry and capillary electrophoresis to ensure sequence accuracy and purity.
Next-generation TdT-based synthesis using engineered terminal deoxynucleotidyl transferase with reversible terminators.
Comprehensive specifications to meet your research requirements.
| Parameter | DNA Oligonucleotides | RNA Oligonucleotides | Gene Synthesis |
|---|---|---|---|
| Length Range | 5 - 200 nt | Up to 300 nt | 100 bp - 15 kb |
| Coupling Efficiency | ≥99.5% | ≥99.0% | NGS verified |
| Turnaround Time | 4-7 business days | 7-12 business days | 7-17 business days |
| Scale Range | 0.025 - 10 μmol | 0.25 - 5 μmol | Custom |
| Purification | Desalt, Cartridge, HPLC, PAGE | HPLC, PAGE, Dual | Standard or custom |
| Modifications | 100+ options | 2'-OMe, 2'-F, LNA | Codon optimization |
Our proven 5-step workflow ensures quality and efficiency at every stage.
Discuss your project requirements and design strategy
Sequence optimization and codon design
Automated synthesis with real-time monitoring
Mass spec, CE, and NGS verification
Secure packaging with comprehensive report
Our synthesis services support research and development in multiple fields.
Custom gRNAs, donor templates, and HDR repair oligos for precise genome engineering applications. Quality matters when you're editing genomes.
ASOs, siRNAs, and aptamers with chemical modifications for enhanced stability and cellular delivery. The field has come a long way since the early therapeutic oligonucleotides.
Adapter sequences, capture probes, and qPCR primers for next-generation sequencing and molecular diagnostics. As sequencing costs keep dropping, demand for high-quality oligos keeps growing.
Trusted by researchers worldwide for quality and reliability.
"The NGS-verified synthesis exceeded our expectations. Sequence accuracy was perfect and the QC report was comprehensive. Highly recommended for any genomics project!"
"Fast turnaround and excellent communication throughout the project. The team provided valuable design recommendations for our CRISPR library. Will definitely use again."
"We've used this service for multiple therapeutic oligonucleotide projects. Consistent quality and professional service every time. Our go-to provider for oligo synthesis."
Our platform is backed by peer-reviewed research.
McKenzie LK, El-Khoury R, Thorpe JD, et al. Chemical Society Reviews. 2021.
Comprehensive review of modified nucleic acids for therapeutic oligonucleotides including ASOs and siRNAs.
Lu X, Li J, Li C, Lou Q, Peng K, Cai B, Liu Y, Yao Y, et al. ACS Catalysis. 2022.
Engineering TdT for enzymatic DNA synthesis with reversible terminators enabling high-throughput automated production.
Featherston AL, Kwon Y, Pompeo MM, Engl OD, et al. Science. 2021.
Breakthrough in catalytic asymmetric synthesis of all possible oligonucleotide stereoisomers.
Ma Y, Zhang Z, Jia B, Yuan Y. Heliyon (Cell Press). 2024.
Comprehensive review of automated synthesis platforms and biofoundries for accurate high-throughput DNA production.
Glazier DA, Liao J, Roberts BL, Li X, Yang K, et al. Bioconjugate Chemistry (ACS). 2020.
Review of chemical synthesis methods for RNA and modified oligonucleotides with simplified workflows.
Find answers to common questions about our service.
Get a customized quote for your DNA and RNA Synthesis Services project. Our experts will respond within 24 hours.
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.